QALGX | VIGRX | QALGX / VIGRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 19 years | 32 years | - |
Gain YTD | 2.447 | 1.354 | 181% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1500 | 3000 | 50% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.42B | 292B | 1% |
Annual Yield % from dividends | 0.00 | 0.43 | - |
Returns for 1 year | 21.14 | 22.56 | 94% |
Returns for 3 years | 41.16 | 53.83 | 76% |
Returns for 5 years | 55.13 | 111.20 | 50% |
Returns for 10 years | 91.15 | 281.67 | 32% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FIJYX | 30.44 | -0.05 | -0.16% |
Fidelity Advisor Biotechnology Z | |||
VGICX | 70.62 | -0.93 | -1.30% |
JPMorgan US Value C | |||
WIISX | 12.89 | -0.18 | -1.38% |
William Blair International Sm Cap Gr R6 | |||
LYRZX | 12.07 | -0.17 | -1.39% |
Lyrical International Value Equity C | |||
HBSGX | 26.20 | -0.98 | -3.61% |
Hartford Small Cap Growth HLS IB |